Nicheloom

Market intelligence for builders — see what's gaining traction before it's crowded.

Nanograb: Deliver mRNA to any cell with AI

Announcing NGX1, a platform for designing multi-peptide targeted lipid nanoparticles (tLNPs)

Details

External ID
115774
Source
YC
Company
Nanograb
Product
Nanograb: Deliver mRNA to any cell with AI
Website domain
nanograb.com
Launched
Sept. 17, 2026
Cohort
Summer 2023
Upvotes
9
Upvotes percentile
0.5833333333333334
Tags
AI-powered Drug Discovery, Nanomedicine, Biotech, Drug Delivery, Therapeutics
Fetched at
Sept. 30, 2026, 5 p.m.
Updated at
Sept. 30, 2026, 5 p.m.

Enrichment

Theme
fruit fly connectome applications
Vertical
Healthcare
Function
Vertical SaaS
Audience
B2B
AI stance
AI-native
Project type
Commercial product
Normalized one-liner
ai design platform for targeted lipid nanoparticles
Manually corrected
False

Could you build this?

No Designing targeted lipid nanoparticles (tLNPs) to deliver mRNA involves specialized wet-lab biology, biophysics, chemistry, and novel biotech ML research.

What it would actually take: Building NGX1 requires specialized ML models trained on proprietary biological assay data regarding cell surface receptors, peptide binding affinities, and nanoparticle formulation dynamics. The stack includes computational biology tools (e.g., AlphaFold/RoseTTAFold derivations, molecular dynamics simulations) paired with an actual wet-lab validation loop to synthesize and test tLNPs. Deep expertise in nanoparticle chemistry, immunology, and computational biochemistry is strictly required.

Competitors

Other products that read as similar to this one — 89 launches clear the similarity bar, closest 8 shown.

Attention rank: #44 of 90 (itself plus its competitors, highest first — normalized so YC and Product Hunt are compared fairly).

Launched 314 days after the earliest competitor.

Other launches for this product

Same idea, different domain

Nobody's really built a vertical saas tool for Insurance yet.